Brief: 3Sbio Enters Into License Agreement With Pfizer
20/05/2025 24:03
May 20 (Reuters) - 3SBio Inc 1530.HK: ENTERING INTO LICENSE AGREEMENT FOR PD-1/VEGF BISPECIFIC ANTIBODY (SSGJ-707) WITH PFIZER POSSIBLE SUBSCRIPTION OF CERTAIN NUMBER OF NEW SHARES OF COMPANY BY PFIZER TO RECEIVE $1.25 BILLION UPFRONT PAYMENT PFIZER WILL SUBSCRIBE FOR US$100 MILLION DOLLARS WORTH OF ORDINARY SHARES OF CO Further company coverage: 1530.HK ((Reuters.Briefs@thomsonreuters.com;))